click on circles to display study description...
anticoagulation, intermediate prophylactic dose (n=276) vs. anticoagulant, prophylactic dose (n=286)
randomized controlled trial
intermediate-dose prophylactic anticoagulation enoxaparin, 1mg/kg daily
standard-dose prophylactic anticoagulation enoxaparin, 40mg daily
COVID-19 severe or critically
open-label
10 academic centers in Iran
2 × 2 factorial design comparing intermediate-dose vs standard-dose prophylactic anticoagulation and statin therapy vs matching placebo
powered by vis.js Network
An extraction panel is open